.png)
.png)
Senior Director, Early Clinical Development
F2G, United Kingdom
Disclosure(s): F2G: Employee
Karen Cornelissen BSc PhD, Senior Director of Early Clinical Development, F2G Ltd
Karen holds a degree in Pharmacology from Portsmouth University, UK and a PhD in Drug Metabolism from University of Bath, UK. She has worked in the field of Clinical Pharamcology at both CROs and big Pharma, working across numerous therapeutic areas. Most recenlty her focus has been upon the field of antifungals, and works for F2G, based in Manchester, UK providing PK support for all aspects of the olorofim development pogram.